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A B S T R A C T
Implanted phrenic nerve stimulation is a technique restoring spontaneous breathing in patients with
respiratory control failure, leading to being dependent on mechanical ventilation. This is the case for
quadriplegic patients with a high spinal cord injury level and for patients with congenital central
hypoventilation syndrome. The electrophysiological diaphragm explorations permits better patient
selection, conﬁrming on the one hand a deﬁnite issue with central respiratory command and on the other
hand the integrity of diaphragmatic phrenic nerves. Today there are two different phrenic stimulation
techniques: the quadripolar intrathoracic stimulation and the bipolar intradiaphragmatic stimulation.
Both techniques allow patients to be weaned off their mechanical ventilator, improving dramatically
their quality of life. In fact, one of the systems (phrenic intradiaphragmatic stimulation) was granted
social security reimbursement in 2009, and now both are reimbursed. In the future, phrenic
intradiaphragmatic stimulation may ﬁnd its place in the intensive care unit, for patients needing it
temporarily, for example, after certain surgeries with respiratory complications as well as diaphragmatic
atrophies induced by prolonged mechanical ventilation.
 2015 Elsevier Masson SAS. All rights reserved.
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www.sciencedirect.comSome neurological pathologies render patients dependent on
mechanical ventilation because of a defect in respiratory command
or respiratory command transmission (‘‘central respiratory paral-
ysis’’), while the main respiratory effector (the diaphragm) remains
intact. This dependence on mechanical ventilation leads to a loss of
autonomy and can make the return home quite difﬁcult for these
patients. Implanted phrenic stimulation is a therapeutic approach
allowing patients to wean off mechanical ventilation.
Historically, the ﬁrst stimulation of the phrenic nerve dates
back from the discovery of electricity. The ﬁrst description of
diaphragmatic contraction induced by phrenic stimulation at neck
level dates back to 1819, on the ‘‘fresh’’ cadaver of a hanged
prisoner [1]. Right from 1829, Jean-Jacques Leroy from Etiolles,
after having described the dangers of too much positive pressure
insufﬂation, recommended calibrating this insufﬂation based on
the weight of the subject, he underlined that the most natural§ This article is the update of an article previously published in France in the
Journal Reanimation, under the reference http://dx.doi.org/10.1007/
s13546-010-0007-3, and part of its content was used here with the authorization
of the above-mentioned Journal.
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1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.mechanical ventilation was the one that could be induced by
stimulating the diaphragm. He put the concept into practice, using
needles inserted in the diaphragm in a cat model [2]. Duchenne de
Boulogne described in details the technique of phrenic stimulation
at neck level and suggested therapeutic applications, in the
rehabilitation of lead poisoning paralysis for example [3]. In the
modern era, the ﬁrst clinical applications of implanted phrenic
stimulations started in the seventies [4]. In France, the ﬁrst activity
in this area was noted in the eighties, by a team from the Berck
PM&R center [5].
The dependence of mechanical ventilation for quadriplegic
patients following a high level spinal cord injury (SCI) is the most
frequent indication for implanted phrenic stimulation [6,7]. Other
indications (congenital or acquired central hypoventilation syn-
drome) are rarer. We estimate that around 50 patients per year
might be concerned by this indication in France. Two techniques
are available today intrathoracic and intradiaphragmatic phrenic
nerve stimulation (see the details in the report published in
2009 by the French Higher Health Authority [HAS], 2009). Today,
both techniques are reimbursed by the French social security
system.
The objectives of this literature review is to cover today’s main
indications and contraindications, detail the two available
techniques and reﬁne the different therapeutic perspectives where
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relevant in years to come.
1. Reminder: physiology and pathophysiology of respiratory
command
The mobilization of lung volumes, necessary for gas exchanges
ensuring respiratory function, is under the dependence of motor
pressures produced by respiratory muscles (Fig. 1). The activity of
these muscles must be maintained all lifelong 24/24, even when
sleeping. The command of these muscles is intrinsic, it stems from
the central nervous system (CNS). This respiratory command is a
dual one, automatic at the level of the brain stem and voluntary at
cortical level. The command is transmitted to the spinal motor
neurons dedicated to respiratory muscles via the bulbospinal and
corticospinal tracts. The automatic motor command sources from
the brain stem at the level of the pre-Bo¨tzinger complex (preBo¨tC)
and the parafacial zone. This command is exclusive during sleep
and is permanently active. It is submitted to numerous mechanical
and metabolic afferents but also supraspinal inﬂuences, coming
from example from the limbic system.
The voluntary respiratory command stems from the cortical
structure belonging to the locomotor system. This command
enables voluntary respiratory maneuvers, such as apnea or
respiratory functional tests.
Motor neurons dedicated to the motor innervation of the
diaphragm form, with the sensory afferents coming from the
diaphragm, the phrenic nerves [8]. They stem from the anterior
part of the anterior grey column (C3, C4 and C5 levels).
The C4 nerve root is considered as the main root (75% of ﬁbers
make up the phrenic nerve). Fibers stemming from these three
roots rapidly unite to make up the phrenic nerve at a height
corresponding approximately to the transversal plane goingFig. 1. Indications of phrenic nerve stimulation. Automatic central drive appears in the brai
C4 and C5) branches and through the phrenic nerves up to the diaphragm. Indication of pthrough the upper rim of the thyroid cartilage where it is covered
by the sternocleidomastoid muscle, it follows a downstream
vertical path. The phrenic nerve receives the accessory phrenic
nerve (stemming from C5) in its supraclavicular portion.
In the thorax, the phrenic nerve, plastered against the pleura,
goes down all the way to the diaphragm in the anterior
mediastinum, bordering the large vessels from the base of the
heart, then the lateral side of the pericardium. In the mediastinum,
both nerves follow a different path: the right one goes straight in a
straight path, vertically, along the superior vena cava and the right
atrium, it approaches the diaphragm on the anteroexternal side of
the inferior vena cava. The left one, which is longer, describes a
wide curve at the left side of the heart and thus approaches the
diaphragm, a little bit backward of the tip of the heart, in a more
anterior and external approach. Both nerves divide in their
terminal branches at the level of the inferior surface (abdominal)
of the diaphragm. There are generally 3 terminal branches.
Thus, the diaphragmatic function can be compromised at three
different levels (Fig. 1):
 at the level of central command or the upper motor neuron;
 at the level of the peripheral phrenic motor neuron or along the
path of the phrenic nerve in the thorax;
 at muscle level.
Implanted phrenic stimulation is then relevant in its validated
indications, presuming the phrenic nerve is intact and there is no
irreversible or progressive diaphragm atrophy. In this regard, these
indications are limited to respiratory central command disorders [9].
2. Surgical techniques
Two phrenic stimulation techniques are nowadays available in
France.n stem, continues along the spinal cord, then through the 3rd, 4th and 5th cervical (C3,
hrenic nerve stimulation is central hypoventilation due to a problem above C4 level.
Fig. 2. Intradiaphragmatic phrenic nerve stimulator (NeurRxDP41, Synapse, Oberlin, Ohio, USA). Four electrodes are implanted in the diaphragm, by laparoscopy.
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Intrathoracic phrenic stimulation is the ‘‘historical’’ technique
(Fig. 2) [9,10]. It is based on radiofrequency transmission via
transmitter coils ﬁxed to the skin, to a receptor implanted under
the skin linked to phrenic electrodes, energy and information
produced and modulated by an external stimulator (Atrostim1,
Atrotech, Tampere, Finland or Avery1, Avery medical System,
USA). The stimulation is bipolar (Avery1) or quadripolar and
sequential (Atrostim1). Electrodes are implanted, via a minimally
invasive thoracotomy, on each phrenic nerve (above the superior
vena cava for the right phrenic nerve, and above the pulmonary
trunk for the left phrenic nerve). It is essential to control the proper
functioning of the electrodes during the surgery, by determining
the stimulation threshold of each electrode, which must be inferior
to 1 mA.
2.2. Intradiaphragmatic phrenic stimulation
This implantation technique is more recent [11] (NeurRxDP41,
Synapse, Oberlin, Ohio, USA) (Fig. 3). Stimulation electrodes are
implanted during laparoscopy, after mapping via stimulationFig. 3. Intrathoracic phrenic nerve stimulator (Atrostim1, Atrotech, Tampere, Finla
subcutaneous receptors receive the information from the cutaneous transmitter coils.during surgery in order identify the phrenic motor point in each
diaphragmatic cupola, two stimulation electrodes are positioned at
this level. Thus, the phrenic nerve is stimulated in its distal part, via
two intradiaphragmatic electrodes. The electrodes are then
tunneled under the skin and connected to the phrenic stimulator
via a connector and a cable.
2.3. Advantages and drawbacks
Intrathoracic phrenic stimulation is the gold standard with
multiple patients implanted all over the world for nearly 40 years.
It guarantees the stimulation of all phrenic ﬁbers, with stimulation
intensities ranging from 1 to 2 mA. It implies nevertheless, a rather
complicated surgery, requiring a thoracotomy, with a potential risk
of phrenic nerve lesion during surgery and a postoperative period
that includes more potential complications than laparoscopy
[12]. This is a costly technique, an Atrostim1 stimulator from
Atrotech (Tampere, Finland) costs about 50,000 s. The intradia-
phragmatic system (Synapse Biomedical, Oberlin, Ohio, USA)
requires a less invasive surgery with the absence of phrenic nerve
lesion risks. This device costs less than 20,000 s. This approach
does not guarantee the stimulation of all phrenic ﬁbers, andnd). Four multipolar electrodes are implanted around the two phrenic nerves,
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effectiveness can be compromised, in patients with no damages to
sensory pathways (congenital or acquired hypoventilation, some
incomplete spinal cord injuries, by pain projected at shoulder level
triggered by the stimulation of sensory phrenic afferents [13]. This
pain can limit the efﬁcacy of stimulation and might require the use
of analgesics targeting neuropathic pain.
3. Indications and contraindications
3.1. Indications
Validated indications for implanted phrenic nerve stimulation
correspond to mechanical ventilation dependence secondary to
respiratory command disorders in the framework of:
 quadriplegia caused by high level SCI (most often post-
traumatic); the objective of stimulation and the weaning, at least
during the day, of mechanical ventilation. Implantation must be
done at a distance from the initial injury, once lesions have
stabilized. We should nevertheless avoid at all costs, denervation
diaphragmatic atrophy, as well as respecting a reasonable 6- to 18-
month delay. However, some delayed implantations, more than
5 years post-injury, were performed successfully [14];
 permanent, or sleep-related central hypoventilation, congenital
or acquired (degenerative pathologies, sequelae from surgical
resection of tumor of the posterior fossa or brain stem, stroke or
encephalitis complications. . .); the objective of stimulation in
this context, in the absence of motor impairments, is to restore a
normal life by freeing the patient from the being on a mechanical
ventilator. Making the indication of stimulation in adult acquired
central hypoventilation is relatively simple, however for Ondine
syndrome the time of implantation has not yet been the object of
a consensus [15]. Phrenic stimulation can be discussed
speciﬁcally when central hypoventilation lingers upon awaken-
ing, especially when sole mechanical ventilation has failed [16].
3.2. Contraindications
Aside from the technique, any lesion of the phrenic nerve is a
contraindication to phrenic stimulation. This lesion can result from
SCI reaching the phrenic motor neuron (SCI at C4), radicular injury
(due to traumatic tear for example) or nerve root injury. The
frequency of such injuries is not known and will then need to be
discarded. Furthermore, phrenic stimulation needs for the
diaphragm to be intact, thus any intrinsic muscle lesion is a
contraindication. The only exception is denervation diaphragmaticFig. 4. Electrophysiological examination of the diaphragm: 1: tracheal pressure probe
stimulation; 6: stimulator.atrophy secondary to spinal cord injury, in fact, the latter will
improve with stimulation rehabilitation. Major malnutrition can
considerably complicate this rehabilitation. The patient’s back-
ground can also constitute a contraindication. Thus the psychologi-
cal or psychiatric state of the patient can be a negative factor for
stimulation, which could contribute to failure. One should also avoid
implanting patients with a progressive pathology that could lead to
death on the short- or medium-term. Finally, the social, family
context and life project must be taken into account in the decision.
3.3. Check-up before implantation
It was essential to evaluate the function of the phrenic nerve
and diaphragm, and to obtain information on central conduction
pathways. In order to do that, patients must undergo phrenic
stimulation [17] with a recording of the electromyography and
mechanical diaphragm responses [18] (Fig. 4). The study of the
diaphragmatic response to transcranial magnetic stimulation gives
information on the status of central conduction pathways,
especially in the framework of acquired central respiratory
paralysis [19]. The absence of response to transcranial stimulation
means a complete interruption of the respiratory command
transmission pathways, erasing any hope of recovery and thus
points towards the indication of phrenic stimulation (if the phrenic
nerve is intact, or infra). A lingering response, on the other hand,
paves the way to potential recovery, and requires further
assessments before taking the decision of implanting [20]. Cervical
magnetic stimulation can ensure the integrity of the phrenic nerve
and the diaphragm [19].
A psychological and social evaluation is also necessary before
posing the indication of implanted phrenic stimulation.
3.4. Alternative therapeutics
Unfortunately, when implanting a phrenic stimulator is
contraindicated because of phrenic nerve affection, there is no
equivalent alternative to propose to the patient. Ventilation by
intermittent abdominal compression can make do for a few hours,
when patients really want be free from the ventilator at neck level.
Abdominal electrical stimulation, used to produce a ‘‘reversed’’
ventilation (active exhaling, passive inhaling via abdominal
relaxation) was the subject of several physiological studies but
no clinical applications yet. A phrenic neurotization protocol,
consisting in re-innervating the phrenic nerve using an upper
laryngeal branch, is ongoing coordinated by a team from Rouen
(Eric Verin and Jean-Paul Marie, see ClinicalTrials.gov,
NCT00213616). Results will not be available until 2016.; 2: EMG electrodes; 3: abdominal belt; 4: EMG test (on the ﬁnger); 5: magnetic
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4.1. Delay in implementation and reconditioning
For intrathoracic stimulation, a postoperative delay of about
10 weeks must be respected, for intradiaphragmatic stimulation a
48-hour delay is sufﬁcient. The stimulation thresholds are veriﬁed
for each electrode.
A period of diaphragmatic strength training is necessary for
quadriplegic patients due to denervation atrophy [10,21]. To
achieve strength training, one session a day is needed beyond the
‘‘fatigue’’ threshold (generally identiﬁed by a 50% decrease in the
common volume usually produced by phrenic stimulation, or
signs of clinical intolerance). The initial duration of stimulation
cannot be predicted, it can be lower than 5 minutes in case of
severe atrophy up to 10 minutes. For the most severe atrophies,
strength training might only be possible under mechanical
ventilation. Stimulation duration initially lasts 10 minutes and
is progressively increased to reach 2 hours daily after 4 weeks
according to the accepted protocol in our service. Strength
training in stimulated respiratory autonomy will then be possible
when the common volume reaches 400 ml. This takes about 4 to
6 weeks.
Clinical follow-up and monitoring of the volume produced is
necessary cycle to cycle in order to ensure the safety of the patient
during the entire strength conditioning rehabilitation. This is done
via an electronic spirometer connected, most times, to the
tracheotomy cannula. Once stability is achieved, measuring
current respiratory volume is only necessary in case of problems.
It is important to underline that in quadriplegic patients,
transferring from a lying down position to a sitting up position is
associated to a decreased efﬁcacy of the diaphragmatic mechanics
due to atonic abdominal muscles [22]. Thus, the setting of the
stimulator must always be done in a sitting up position, and
usually with an abdominal contention. This contention must not
cover the areas of the costal diaphragm’s insertion as it might
reduce the diaphragmatic effectiveness.
4.2. Monitoring and follow-up
Once the muscle strengthening rehabilitation period is over, the
risk of diaphragmatic muscle fatigue on the short- and long-terms
is weak, almost absent. The risk of injury to the phrenic nerve or the
diaphragm induced by stimulation is rather improbable, as
validated by the effectiveness of phrenic stimulation in patients
with a 20-year follow-up [12,23–25]. In practice, stimulation
duration depends essentially on the patient’s wishes and most of
all the possibility of nighttime respiratory monitoring. As a matter
of fact, contrarily to mechanical ventilators, stimulators are not
equipped with devices monitoring their own effectiveness, and do
not have any alarms for empty batteries or electronic dysfunctions.
Thus, in the absence of nighttime monitoring, it is recommended to
use mechanical ventilation at night.
4.3. What to do with the tracheotomy?
Tracheotomy closure is possible, regularly performed in the
USA, in quadriplegics as well as in patients with central
hypoventilation. However, it raises two types of issues. On the
one hand, it renders difﬁcult the access to the upper respiratory
tract and requires intubation, when surgery is needed, or in case of
vital emergency (included one triggered by stimulator dysfunc-
tion). On the other hand, phrenic stimulation is not a physiological
inspiration, the diaphragmatic contraction it induces is not
preceded by an opening of the upper respiratory airways and is
not associated with a contraction of the upper chest wall musclesto stabilize the former, leading to a paradoxical movement of the
upper part of the chest wall during the diaphragmatic contraction
[26] exerting pressure forces on the upper respiratory tract. This
brings a risk of obstruction of the upper respiratory tract during
inspiration induced by phrenic stimulation [27].
4.4. Precautions and dysfunction risks
Phrenic stimulators do not induce any risks for pacemakers [28].
Magnetic resonance imaging (MRI) and lithotripsy are totally
contraindicated with the intrathoracic phrenic stimulator because
of the risk of electromagnetic interferences. This imaging
technique remains also contraindicated to date for the intradia-
phragmatic stimulator. Conversely, standard X-rays and CT-scans
are not contraindicated, neither are electric surgical blades.
Finally, covering the phrenic stimulator’s transmitter coils with a
metallic rescue blanket immediately interrupt the transmission of
information and thus the phrenic stimulation stops completely [29].
The life duration of these stimulators is unknown but it seems
to be around 10 years for the intrathoracic stimulator, as internal
components often need to be replaced after this time period. For
the intradiaphragmatic stimulator the life duration is unknown as
we do not have yet a 10-year follow-up for the ﬁrst implanted
patients.
5. Results
Since the seventies, there have been thousands of phrenic
stimulator implantations. This technique enabled the weaning of
several patients from mechanical ventilation. Nevertheless, most
studies available in the literature are observational ones,
sometimes comparative but retrospective, making it quite difﬁcult
to quantify precisely the beneﬁts of implanted phrenic stimulation
vs. mechanical ventilation, even if these beneﬁts are undeniable
[25].
5.1. Weaning from mechanical ventilation
Historical studies have been made all with the Atrotech1
intrathoracic implantation system. The largest international,
multicenter study had a cohort of 64 patients with 35 children
and 29 adults [12]. Implanted phrenic stimulation was in most cases
indicated in post-traumatic quadriplegia (71%) or congenital central
hypoventilation syndrome (22%). The stimulation was judged
successful with no complications in 60% of children and 52% of
adults. Complications reported were: 6% of infection cases, 3.8% of
iatrogenic trauma to the phrenic nerve, 3.1% of electrode dysfunction
and in 5.9% of the cases a receptor dysfunction. After repair, the
stimulation was evaluated as effective in 94% of pediatric patients
and 86% of adult patients. Another monocenter study reported
weaning from mechanical ventilation in 81% of patients most of
them with post-traumatic quadriplegia (72%) [30]. Most recently, a
North American center reported its experience, since 2000, with the
intradiaphragmatic implantation technique (Synapse1). Forty-nine
patients with a high level of SCI were implanted with complete
weaning from mechanical ventilation in 96% of cases [31].
5.2. Quality of life improvements
The possibility of weaning from external mechanical ventila-
tion thanks to implanted phrenic stimulation leads to an incredible
autonomy. In quadriplegic patients, this device makes nursing care
(washing, transfer to a wheelchair) and daily life (returning home)
[32,33] easier thanks to the end of being hooked to the external
mechanical ventilation device. Furthermore, for some patients, the
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the change in medicalized structure (for example leaving the ICU
for a PM&R Center). Finally, phrenic stimulation frees patients and
their family from the auditory nuisance related to the mechanical
ventilation device.
In some quadriplegic patients, the device restores phonation,
which was impossible under mechanical ventilation because of the
poor tolerance to non-invasive ventilation. Finally, phrenic
stimulation restores the air ﬂow via the upper respiratory tract
and, therefore, olfactory sensations [35]. This result is part of the
main factors reported by patients in their self-assessed quality of
life improvements.
5.3. Decrease in morbidity-mortality
Continuous positive airway pressure promotes the onset of
thromboembolic complications by reducing the intrathoracic
blood ﬂow, as observed in ICU patients [36]. Conversely, implanted
phrenic stimulation creates a negative pressure in the thorax, thus
improving the venous return, which should theoretically reduce
the risk of thromboembolic complications in quadriplegic patients.
Nevertheless, this has not been formerly validated to this day.
Tracheotomy-related complications such as tracheal lesion or
tracheoesophageal ﬁstula are promoted by a conﬂict between the
canula and the trachea, occurring for example when patients are
mobilized. Thus it is quite probable that implanted phrenic
stimulation might reduce the frequency of tracheal lesions by
limiting the tracheal injuries induced by mechanical ventilation
[14,34].
The expected medical beneﬁt resides mostly in the reduction of
infectious complications. As a matter of act, implanted phrenic
stimulation enables a more physiological inspiration and improves
bronchial secretion draining, while reducing lung base atelectasis.
In fact, the frequency of bronchial aspirations and bronchial and
pulmonary infections are often less frequent under stimulation
[24].
Finally, implanted phrenic stimulation privileges the ventila-
tion of the bases of the lungs by improving the blood ﬂow. This
phenomenon probably explains the reduction in oxygen of the
alveolar–arterial gradient validated under stimulation vs. mechan-
ical ventilation, for similar levels of ventilation [37].
6. Conclusions and perspectives
Within a group of carefully selected patients (proper indica-
tions, satisfactory electrophysiological explorations), implanted
phrenic stimulation can restore an independent ventilation with
medical beneﬁts and most likely economical ones as well. This led
the French Higher Health Authority (HAS) to consider in May 2009,
that the beneﬁt was sufﬁcient to instruct social security to
reimburse implanted phrenic stimulation. The data available today
justify that any potentially eligible patient should be offered this
therapeutic approach, and receive detailed information about it.
However, the target population remains extremely limited in the
indications validated to this day. This population could increase in
light of the results recently obtained in central sleep apnea and
intermittent ventilation [38], showing that implanted phrenic
stimulation can efﬁciently correct these disorders and conse-
quently, maybe, reduce associated morbidity and mortality. In a
particularly promising manner for the future of this technique,
these results in central sleep apnea could be obtained thanks to the
development of endovascular phrenic stimulators (so-called
‘‘transvenous’’ phrenic nerve stimulation), which do not require
a surgical approach and are fully implantable (remede¯ System1,
Respicardia, Minneapolis, USA).Moreover, other applications of implanted phrenic stimulation
are being studied, not just to promote ventilatory assistance, as in
disorders of central command, but to correct or prevent
diaphragmatic atrophy. Thus, the hypothesis was brought up that
implanted phrenic stimulation could slow down diaphragmatic
degeneration in amyotrophic lateral sclerosis (ALS) [39]. Several
large-scale controlled studies are underway to determine if
implanted phrenic stimulation could increase the survival of
patients with ALS, or delay the need for mechanical ventilation
(French study ‘‘RespiStimSLA’’, NCT01583088, the ﬁrst results
should be available in 2016 or 2017). Implanted phrenic
stimulation could then decrease respiratory complications in-
duced by at-risk surgery (cardiac, supramesocolic abdominal). It
would seem important to have the possibility to implement a
temporary stimulation, thanks to electrodes that would be easy to
set-up and remove. This possibility could be offered on the short-
term, such as in central sleep apnea (see above), via the
transvenous phrenic approach, using catheters inserted via the
supraclavicular approach [38] (LungPacer1, Lungpacer medical,
Burnaby, BC, Canada). Transvenous phrenic stimulation could lead
way to a wide range of applications in intensive care, as an
adjuvant treatment to mechanical ventilation assistance. In fact,
preliminary data suggest that it could prevent the diaphragmatic
dysfunction inducted by mechanical ventilation [40,42], and could
then help limit the impact of this dysfunction on weaning from
ventilation.
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